NITRESAN

This brand name is authorized in Estonia, Lithuania, Poland.

Active ingredients

The drug NITRESAN contains one active pharmaceutical ingredient (API):

1
UNII 9B627AW319 - NITRENDIPINE
 

Nitrendipine is a dihydropyridine calcium channel blocker. It is used in the treatment of primary hypertension to decrease blood pressure.
 
Read more about Nitrendipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C08CA08 Nitrendipine C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1261820, 1261831, 1261842, 1261853, 1261864, 1261875, 1261886, 1261897, 1404380, 1404391
LT Valstybinė vaistų kontrolės tarnyba 1005019, 1005454, 1030070, 1030071, 1030072, 1030073, 1030074, 1030075, 1052879, 1052880
PL Rejestru Produktów Leczniczych 100192284, 100245106

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈